The Institute of Technology in Immunobiologicals (Bio-Manguinhos) is the technical-scientific unit of the Oswaldo Cruz Foundation (Fiocruz) that produces and develops immunobiologicals to meet the demands of public health. Its product line consists of vaccines, reagent kits for laboratory diagnosis and biopharmaceuticals. Founded in 1976, Bio-Manguinhos is a reference in the sector and occupies a prominent position in the market. | The Institute of Technology on Immunobiologicals (Bio-Manguinhos) is the unit of the Oswaldo Cruz Foundation (Fiocruz) responsible for research, innovation, technological development and production of vaccines, in vitro diagnostics (IVDs), biopharmaceuticals and advanced therapies primarily aimed at meeting the demands of Brazilian Public Health System (SUS), besides providing technological services. The Institute also contributes with the public health of several countries, mainly by the supply of the yellow fever vaccine, pre-qualified by WHO. With 49 years of existence, it has become the largest federal laboratory in Latin America and has consolidated itself as a strategic agent of public health policies in Brazil, having been selected by WHO/OPAS as Hub for mRNA COVID-19 Vaccine production to Latin America and Caribbean. To keep up with the trends and best practices in the pharmaceutical industry, the investment in the expansion and modernization of infrastructure is constant, being part of the innovation process of Bio-Manguinhos. With its own technological development projects and partnerships, in addition to technology transfer agreements with public and private institutions, the Institute provides a range of products for the Brazilian Public Health System (SUS), through the programs of the Ministry of Health. In the period from 2019 to 2024, there were approximately 800 million doses of vaccines delivered to the National Immunization Program; more than 66 million reagent kits for laboratory diagnosis; and 35 million bottles/syringes of biopharmaceuticals. Bio-Manguinhos products guarantee free access to high-tech immunobiologicals by the Brazilian population and allow the reduction of expenses by the Ministry of Health. This leading role in the field of public health is the result of the commitment of 2,400 employees who make the difference in the lives of millions of people every day.
Finamac
Finamac™ is synonymous of quality, tradition and commitment in the ice cream equipment sector, being the only company in Latin America to have its own engineering sector, which for over 30 years has been developing a series of technological innovations that have already benefited several ice cream producers around the world.
Finao Biotech
FINAO Biotech is a pharmaceutical company specializing in biotechnology, based in Rio de Janeiro, Brazil with global reach. Our goal is to serve, to improve the quality of life of our customers through a range of innovative products based on sustainable development, production, distribution and commercialization of medicines, innovative medical devices, cosmetics, food supplements and veterinary. At FINAO Biotech we care about society and the environment. Our innovative medical products, highly efficient, reflect our concerns and represent our strength in doing more and better, combining technology with the environment and society. Words like efficiency and sustainability have accompanied our company. The search for the best pharmaceutical development solutions has made FINAO Biotech’s portfolio broader, with a range of innovative products.
Feed&Food Magazine
feed&food Magazine is currently the voice of the animal protein segment and of its entire production chain, starting with the ingredients, premixes, supplements, animal rations, genetics of production animals, animal health, with the complete line of therapeutic and biologic products, equipments and animal welfare handling. feed&food is also MULTIMEDIA (Magazine printed and on-line version + Website + APP for Smartphone and Tablets).
FAST2MINE
Fast2Mine is a mining technology company specialized in real-time operational management and decision support systems. Built by mining and technology specialists, the company delivers modular and scalable solutions that connect field operations, equipment, and data into a single digital ecosystem. Its MMS platform integrates production, maintenance, fuel management, telemetry, safety, and business intelligence, enabling mining operations to increase productivity, reduce costs, and improve operational control with fast deployment and high reliability. Designed to adapt to different mine sizes and levels of digital maturity, Fast2Mine supports data-driven decision-making and sustainable mining practices worldwide. | FAST2Mine specializes in cutting-edge operations and fleet management systems for the mining industry. With over 60 successful projects implemented, our solutions are meticulously designed to overcome the challenges of mining operations and deliver tangible results even in the most extreme scenarios. At FAST2Mine, we prioritize meeting miners’ needs by offering fast-to-implement, user-friendly, flexible, and reliable solutions driven entirely by data. Our software seamlessly integrates with your crew and fleet routines, providing relevant data to support your decision-making processes. Recognizing the profound impact of mining on society, we are committed to leveraging technology to enhance the operational intelligence of mining operations and revolutionize the industry. Hence, our purpose is to share a sustainable future through the transformation of the mining industry and, thus, build a future of more opportunities and quality of life for people. | Fast2Mine is a global Mining Management System provider revolutionizing mining with exponential growth and cutting-edge technology. Operating in the Americas and Oceania, it powers 80+ mines, including world-class names like Kinross, Alcoa, and Gerdau. Managing 6,000+ equipment and 20,000+ users, Fast2Mine sets new standards in the industry.
Farmabase Animal Health
FARMABASE is a benchmark Brazilian company in the development and manufacture of pharmaceuticals for poultry and swine. FARMABASE was a pioneer to be GMP – Good Manufacturing Practices – certified and achieved the leadership of the markets in which it operates. Through development of new tools to promote poultry and porcine health, Farmabase has a highly specialized team of veterinarians, pharmacists and chemists who work to provide the best animal health solutions to the market.